Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Mark Zdechlik

2 top execs leave medical marijuana manufacturer LeafLine Labs

LeafLine Labs
Marijuana plants are grown at LeafLine Labs in Cottage Grove, Minn.
Jeffrey Thompson | MPR News 2015

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

LeafLine Labs said its chief medical officer and chief financial officer have left the company, effective Thursday, the company's CEO said in a statement.

Co-founder and Chief Medical Officer Gary Starr and Chief Financial Officer Colin Kelley departed "due to both personal and professional reasons," said Andrew Bachman, LeafLine Labs' CEO, who also founded the company.

In a brief statement, Bachman said, they "deeply value the contributions" of both executives. Bachman added "our focus remains on caring for our patients, and the future of Minnesota's truly medicinal program."

Company representatives declined to comment further.

The Cottage Grove firm employs 70 people. It has a 42,000-square foot cultivation and production facility and operates four "cannabis patient care clinics" in Minnesota, according to the company's website.

LeafLine Labs and Minnesota Medical Solutions, of Minneapolis, are the only licensed medical marijuana producers in Minnesota.

The Associated Press reported in May the two companies lost a combined $11 million in their first two years of sales.

Leadership changes are not new to LeafLine. Almost two years ago, CEO Manny Munson-Regala resigned eight months after leaving his medical marijuana oversight role with the Minnesota Department of Health to join the company.